Multiclass Classifier for P-Glycoprotein Substrates, Inhibitors, and Non-Active Compounds | JoVE Visualize

Area of Science:

Pharmacology
Computational Chemistry
Toxicology

Background:

P-glycoprotein (P-gp) is a key transmembrane efflux pump influencing drug absorption, distribution, metabolism, excretion, and toxicity (ADMET).
Understanding P-gp interactions is crucial for drug discovery and toxicological assessments to prevent intracellular accumulation and reduce drug toxicity.
Identifying compounds that interact with P-gp is essential for developing safer and more effective drug candidates.

Purpose of the Study:

To develop a robust in silico multiclass classification model for predicting the probability of a compound interacting with P-glycoprotein (P-gp).
To utilize a counter-propagation artificial neural network (CP ANN) and 2D molecular descriptors for P-gp ligand prediction.
To provide a reliable virtual screening tool for early-stage identification of potential P-gp ligands in drug development.

Main Methods:

Development of a multiclass classification model using a counter-propagation artificial neural network (CP ANN).
Training and testing the model on an extensive dataset of 2512 compounds, categorized as P-gp inhibitors, substrates, or non-active compounds.
Validation of the model's performance using an independent external validation set of 385 compounds.

Main Results:

The in silico model demonstrated strong classification performance with high non-error rate (NER) and average precision (AvPr) values on training and test sets.
The model achieved NER and AvPr values of 0.93 and 0.93 on the training set, and 0.85 and 0.87 on the test set, respectively.
External validation yielded NER and AvPr values of 0.70, indicating good generalizability for predicting P-gp ligand potential.

Conclusions:

The developed in silico classifier is an effective tool for virtual screening of potential P-gp ligands.
This computational approach can significantly aid in the early stages of drug discovery and toxicological evaluation.
The model contributes to predicting drug ADMET properties by assessing P-gp interaction probabilities, thereby enhancing drug safety.